Salutas Pharma GmbH, Germany
| Държава: | Германия |
| Кратка информация: | History The roots of Salutas Pharma GmbH can be traced back over 120 years. More than that: their founding fathers have with their research results at the end of the 19th Century truly sustainable and written history. 1878 saw the Dr. Constantin Fahlberg, a chemist in the implementation of sugar analysis, purely by chance as a by-product is a sweet substance: Saccharin, the first artificial sweetener, which sweetens still 500 times stronger than conventional sugar everyday. This discovery was also the birth of the company's success, with the commissioning of the world's first Saccharinfabrik in Magdeburg in 1886, took its course. The pharmaceuticals division established in 1912 expanded the range of products the company also to the medical field. In the GDR, the work counted first as VEB Fahlberg-List, since 1979 as part of the conglomerate agrochemical Piesteritz, the most important drug plants in the country and produced not only for its own market, but also serves customers in Russia, the Czech Republic and Poland. Forerunner of the production Salutas HEXAL Pharma GmbH in Magdeburg Barleben: The company Fahlberg-List After the privatization by the Trust in 1990 the company operated initially as a chemical and pharmaceutical factories Fahlberg-List GmbH, the pharmaceutical branch operating funds shortly thereafter went into the Salutas Pharma GmbH, a subsidiary of Hexal AG, Holzkirchen, above. From 1992 was built on the new premises in Barleben the-art manufacturing and logistics center, which is in full operation since 1995 and is continually expanding. Since a large part of the processed drugs on the production line was HEXAL, favorable synergies ensured a smooth continuation of production. In February 2005 the contract for the acquisition of Hexal and Hexal by Novartis signed with Sandoz, the generics division of Novartis incorporated. Thus, the world's second-largest generics company emerged worldwide with more than 20,000 employees and staff. Sandoz moved its headquarters from Vienna (A) and plans for wooden churches with a long-term investment approach to further expand in Germany. First and foremost the development of the capacity expansion is on a year over 10 billion tablets and capsules at the Salutas Barleben. Salutas Pharma GmbH has established itself as an important manufacturing and logistics operations within the group and established a firm place in the global network of Sandoz. |
| Сайт: | http://www.salutas.de/ |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
